Christopher E. Hart

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Ionis Pharmaceuticals (United States)30.9%
• Harvard University8.1%
• Alnylam Pharmaceuticals (United States)8.1%
• University of Massachusetts Chan Medical School7.8%
• Broad Institute6.6%
• Inserm4.6%
• Other33.9%

Fields

• Biochemistry, Genetics and Molecular Biology69.3%
• Medicine19.5%
• Neuroscience4.3%
• Immunology and Microbiology2.3%
• Computer Science1.8%
• Agricultural and Biological Sciences1.1%
• Other1.8%

Topics

• RNA Interference and Gene Delivery18.4%
• Advanced biosensing and bioanalysis techniques16.1%
• DNA and Nucleic Acid Chemistry12.7%
• RNA Research and Splicing7.2%
• CRISPR and Genetic Engineering7.2%
• RNA and protein synthesis mechanisms6.8%
• Other31.7%